Treating depression in older cancer patients

Article

Depression in older cancer patients is unfortunately common and often goes unrecognized and untreated. The American Cancer Society estimates about 1 in 4 people with cancer may have clinical depression, that is, not just having a bad day but feeling distress that impairs daily life and that lasts for several weeks or more. This is a problem because depressed cancer patients may feel less motivated to follow treatment plans, may not eat well or exercise, and may not care about getting better. However, there is hope, according to results published this week in the Journal of General Internal Medicine from the Improving Mood-Promoting Access to Collaborative Treatment (IMPACT) study. Cancer patients were divided into two groups, one receiving IMPACT and the other receiving usual care. After six months, 55 percent of IMPACT patients showed a 50 percent or greater reduction in depressive symptoms. Of the usual care patients, about 34 percent showed a reduction in symptoms. In addition, IMPACT patients experienced greater remission rates, less fatigue, more depression-free days, and greater quality of life than the usual care patients. The IMPACT program differs from usual care in that participants work with a depression care manager in their primary care provider's office or clinic. The depression care manager provides counseling, medication, or a combination of both to the patient and is supervised by a psychiatrist and the primary care physician. The IMPACT program was tested across the country in primary care facilities that serve a variety of socioeconomic and ethnic populations. With the growing number of older cancer patients and survivors, it is important to have options, especially outside specialized cancer centers. Hopefully, results from the IMPACT study will increase the availability of depression care managers in primary care facilities, which will result in more patients and survivors being treated for this serious medical condition.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content